Short Interest in HCW Biologics Inc. (NASDAQ:HCWB) Grows By 905.4%

HCW Biologics Inc. (NASDAQ:HCWB) saw a large growth in short interest in the month of February. As of February 15th, there was short interest totalling 835,500 shares, a growth of 905.4% from the January 31st total of 83,100 shares. Based on an average trading volume of 6,100,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 3.6% of the company’s shares are short sold.

HCW Biologics Price Performance

Shares of HCWB stock opened at $0.38 on Friday. The stock has a market capitalization of $16.93 million, a PE ratio of -0.38 and a beta of 0.81. HCW Biologics has a 1-year low of $0.21 and a 1-year high of $2.52. The business has a 50-day moving average of $0.39 and a 200 day moving average of $0.47.

About HCW Biologics

HCW Biologics Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.